Bank Of Nova Scotia Bristol Myers Squibb CO Transaction History
Bank Of Nova Scotia
- $47.5 Billion
- Q1 2024
A detailed history of Bank Of Nova Scotia transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Bank Of Nova Scotia holds 940,805 shares of BMY stock, worth $39.1 Million. This represents 0.11% of its overall portfolio holdings.
Number of Shares
940,805
Previous 1,390,331
32.33%
Holding current value
$39.1 Million
Previous $71.3 Million
28.48%
% of portfolio
0.11%
Previous 0.14%
Shares
13 transactions
Others Institutions Holding BMY
# of Institutions
2,554Shares Held
1.49BCall Options Held
25.9MPut Options Held
20M-
Vanguard Group Inc Valley Forge, PA186MShares$7.73 Billion0.2% of portfolio
-
Black Rock Inc. New York, NY163MShares$6.75 Billion0.21% of portfolio
-
State Street Corp Boston, MA91.6MShares$3.8 Billion0.23% of portfolio
-
Jpmorgan Chase & CO New York, NY88.8MShares$3.69 Billion0.44% of portfolio
-
Capital International Investors Los Angeles, CA70.2MShares$2.92 Billion0.79% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $88.3B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...